BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 13, 2007
View Archived Issues
Novel cPLA2alpha inhibiting activity reported for the immunosuppressant agent FTY-720
Read More
Guidelines devised for photodynamic therapy for nonmelanoma skin cancer
Read More
Thymosin beta 4 modulates NF-kB inflammatory signaling in corneal epithelium
Read More
Recent Banyu patent imparts novel analgesic agents
Read More
Recent patents report novel therapeutic agents for HIV infection
Read More
Clinical trial data reveal safety and efficacy of infliximab in psoriasis
Read More
GSK and XenoPort sign agreement for XP-13512
Read More
Wound healing-accelerating effects of estradiol to be studied in patients requiring skin grafting
Read More
GSK and Fabre-Kramer sign global agreement for gepirone ER
Read More
Plethora studies PSD-597 as analgesic therapy in urogynecological procedures
Read More
Corautus Genetics and VIA Pharmaceuticals to merge
Read More
Enrollment open in pilot venous leg ulcer study of Celaderm
Read More
Phase IIa study of LAB's GHRH completes enrollment
Read More
Critical Biologics closes Series A financing in support of rhu-pGSN development
Read More
First large-scale HIV trial begins in South Africa
Read More
Iclaprim safe in subjects with renal and hepatic impairment and obesity
Read More
Once-daily Xibrom formulation effective in treating postoperative ocular pain
Read More
Apotherapy CD40 research program receives E.U. funding
Read More
Ostabolin-C meets primary endpoint in phase II osteoporosis study
Read More
Low-dose interferon alpha lozenges studied for HIV patients with oral warts
Read More
ViaCell will not advance CB-001 based on phase I findings
Read More
Gilead and Achillion advance NS4A antagonist collaboration
Read More
Nuvo discusses Pennsaid approvable letter requirements with FDA
Read More
AGS-004 studied in phase I/II trial in HIV-infected adults
Read More
Guangdong Lantai Viewland to develop MIV-160 for China
Read More
Nexavar extends survival in advanced hepatocellular carcinoma
Read More
Recent patents describe new treatments for endocrine-related disorders
Read More
Danish approval for phase I study of novel anticoagulant TB-402
Read More